Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Agios Pharmaceuticals, Inc. (AGIO) has a Wall Street consensus price target of $41.50, based on estimates from 29 covering analysts. With the stock currently trading at $30.23, this represents a potential upside of +37.3%. The company has a market capitalization of $2.25T.
Analyst price targets range from a low of $25.00 to a high of $62.00, representing a 89% spread in expectations. The median target of $39.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 22 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, AGIO trades at a trailing P/E of -4.2x. Analysts expect EPS to grow +5.5% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how AGIO stacks up against sector leader GRAIL, Inc..
Start ComparisonThe consensus Wall Street price target for AGIO is $41.5, representing 37.3% upside from the current price of $30.23. With 29 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
AGIO has a consensus rating of "Buy" based on 29 Wall Street analysts. The rating breakdown is predominantly bullish, with 22 Buy/Strong Buy ratings. The consensus 12-month price target of $41.5 implies 37.3% upside from current levels.
AGIO's current price is $30.23 with a consensus target of $41.5 (37.3% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $62 for AGIO, while the most conservative target is $25. The consensus of $41.5 represents the median expectation. These targets typically reflect 12-month expectations.
AGIO is heavily covered by Wall Street, with 29 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 22 have Buy ratings, 7 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AGIO stock forecast based on 29 Wall Street analysts shows a consensus price target of $41.5, with estimates ranging from $25 (bear case) to $62 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on AGIO, with a "Buy" consensus rating and $41.5 price target (37.3% upside). 22 of 29 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AGIO analyst price targets range from $25 to $62, a 89% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $41.5 consensus represents the middle ground.